The endocannabinoid system and the treatment of mood and anxiety disorders.

Author(s): Hill MN, Gorzalka BB

Laboratory of Neuroendocrinology, The Rockefeller University, New York, NY, USA

Subject: Mood Disorders View the study

Abstract:

The central endocannabinoid system is a neuroactive lipid signalling system in the brain which acts to control neurotransmitter release. The expression patterns of this system throughout limbic regions of the brain ideally situate it to exert regulatory control over emotional behaviour, mood and stress responsivity.

Source: CNS & Neurological Disorders (Price: $58)
Share Tweet

More medical studies related to Mood Disorders:

View all medical studies >>

Subscribe for daily cannabis news, announcements, and business insights.

Велосипеды fuji www.velotime.com.ua
удаление татуировок одесса

www.diploma-home.com/city-diplom-v-barnaule.html